Li Mengyi, Li Hanbin, Zhong Wen, Wang Shiqi, Liu Rui, Cheng Hongxin, Li Lijuan, Wei Quan, Wang Lu
Rehabilitation Medicine Center and Institute of Rehabilitation Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
Key Laboratory of Rehabilitation Medicine in Sichuan Province, Chengdu 610041, China.
J Clin Med. 2025 Jun 23;14(13):4464. doi: 10.3390/jcm14134464.
The hemoglobin-to-red blood cell distribution width (RDW) ratio (HRR) reflects the status of inflammation and oxidative stress size. Previously, it has been suggested that HRR is associated with cardiovascular diseases (CVD). However, evidence has been limited for examining the association between HRR and the incidence of specific cardiovascular events (e.g., cardiovascular disease, stroke, congestive heart failure) and all-cause cardiovascular death and non-cardiovascular death, adjusting for known confounders. : Data from the National Health and Nutrition Examination Survey (NHANES) in the year cycle of 1999-2018 were collected. HRR was calculated as the ratio of hemoglobin divided by the RDW. The outcomes were CVD, including stroke, congestive heart failure, atherosclerotic cardiovascular diseases (ASCVD), coronary artery disease as well as all-cause death including cardiovascular death and non-cardiovascular death. Univariate and multivariate analyses were performed to explore the association between HRR and outcomes. Restricted cubic spline curves were delineated. : In total, 47,719 participants were eligible for further analysis. In multivariate analysis adjusting for all confounding factors, higher HRR levels were significantly associated with a decreased risk of CVD. Compared to Q1 (<9.86), the odds ratio (OR) and 95% confidence intervals (95% CI) in Q2 (9.86-10.96), Q3 (10.96-11.97), and Q4 (≥11.97) were 0.79 (0.66, 0.94), 0.59 (0.48, 0.73), and 0.53, (0.42, 0.67), respectively, for predicting CVD. Similar results were observed for different subtypes of CVD, including stroke, congestive heart failure, and ASCVD. Notably, for predicting coronary heart disease, only Q3 was significant compared to Q1 (0.70, [0.54, 0.92], = 0.010). HRR was significant for predicting all-cause death, cardiovascular death, and non-cardiovascular death. Additionally, HRR had the highest discriminative ability for predicting all-cause death compared with that of hemoglobin and RDW. : A higher HRR was associated with a lower risk of CVD and death. Moderate levels of HRR were associated with the lowest risk for coronary heart disease. HRR had better discriminative ability than hemoglobin and RDW.
血红蛋白与红细胞分布宽度(RDW)比值(HRR)反映了炎症和氧化应激的程度。此前有研究表明,HRR与心血管疾病(CVD)相关。然而,在调整已知混杂因素后,关于HRR与特定心血管事件(如心血管疾病、中风、充血性心力衰竭)的发生率以及全因心血管死亡和非心血管死亡之间关联的证据有限。收集了1999 - 2018年国家健康与营养检查调查(NHANES)年度周期的数据。HRR计算为血红蛋白除以RDW的比值。研究结果包括CVD,如中风、充血性心力衰竭、动脉粥样硬化性心血管疾病(ASCVD)、冠状动脉疾病以及全因死亡,包括心血管死亡和非心血管死亡。进行单因素和多因素分析以探讨HRR与研究结果之间的关联,并绘制了受限立方样条曲线。共有47719名参与者符合进一步分析的条件。在调整所有混杂因素的多因素分析中,较高的HRR水平与CVD风险降低显著相关。与第一四分位数(<9.86)相比,第二四分位数(9.86 - 10.96)、第三四分位数(10.96 - 11.97)和第四四分位数(≥11.97)预测CVD的比值比(OR)及95%置信区间(95%CI)分别为0.79(0.66,0.94)、0.59(0.48,0.73)和0.53(0.42,0.67)。对于CVD的不同亚型,如中风、充血性心力衰竭和ASCVD,也观察到了类似结果。值得注意的是,对于预测冠心病,与第一四分位数相比,只有第三四分位数具有显著性(0.70,[0.54,0.92],P = 0.010)。HRR对于预测全因死亡、心血管死亡和非心血管死亡具有显著性。此外,与血红蛋白和RDW相比,HRR在预测全因死亡方面具有最高的判别能力。较高的HRR与较低的CVD和死亡风险相关。中等水平的HRR与冠心病的最低风险相关。HRR比血红蛋白和RDW具有更好的判别能力。